One stage mastopexy augmentation in the ptotic patient. The superiorly based dermal flap for autologous reinforcement of the inferior pole

Augmentation-Mastopexy: Analysis of 95 Consecutive Patients and Critical Appraisal of the Procedure

“…On the one hand, autologous mastopexy-augmentation techniques are promoted in the literature because of their safety and natural aesthetic results [3]. For instance, a dermal or glandular flap can be created to avoid pseudoptosis in the long term and to provide breast support [14]. Di Summa et al described a technique based on the creation of dermal triangular flaps in order to create lower pole fullness and prevent ptosis [15].…”

“…With regard to wound infection, this occurred in five patients in group I (26.3%), three patients in group II (9.4%), and two patients in group III (4.5%). The median time to occurrence was 14 (7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21) days. Because of the small sample sizes and the high impact of confounding factors, no signifi-cant differences were found comparing the groups with regard to specific complications including hematoma (median time to occurrence < 5 h), seroma (median time to occurrence 17.5 (14-21) days), capsular contracture (median time to occurrence 40 (36-48) months), double bubble deformity (median time to occurrence 39 (36-45) months), intense scarring (median time to occurrence 6 (0.5-36) months), and rupture (time to occurrence 40 months).…”